DE2551214C2 - Verfahren zur Herstellung von 1,3-oxygenierten 8α-Östratrienen - Google Patents

Verfahren zur Herstellung von 1,3-oxygenierten 8α-Östratrienen

Info

Publication number
DE2551214C2
DE2551214C2 DE19752551214 DE2551214A DE2551214C2 DE 2551214 C2 DE2551214 C2 DE 2551214C2 DE 19752551214 DE19752551214 DE 19752551214 DE 2551214 A DE2551214 A DE 2551214A DE 2551214 C2 DE2551214 C2 DE 2551214C2
Authority
DE
Germany
Prior art keywords
acid
general formula
solution
compounds
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19752551214
Other languages
German (de)
English (en)
Other versions
DE2551214A1 (de
Inventor
Ulrich Dipl.-Chem. Dr. Eder
Gregor Dipl.-Chem. Dr. Haffer
Günter Dipl.-Chem. Dr. Neef
Gerhard Dipl.-Chem. Dr. Sauer
Rudolf Prof. Dipl.-Chem. Dr. 1000 Berlin Wiechert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to DE19752551214 priority Critical patent/DE2551214C2/de
Priority to DK476376A priority patent/DK137682C/da
Priority to CH1404576A priority patent/CH623061A5/de
Priority to GB4638576A priority patent/GB1571181A/en
Priority to LU76163A priority patent/LU76163A1/xx
Priority to FR7634119A priority patent/FR2331568A1/fr
Priority to BE172327A priority patent/BE848301A/xx
Priority to US05/741,497 priority patent/US4066674A/en
Priority to NL7612609A priority patent/NL7612609A/xx
Priority to JP13619776A priority patent/JPS5262264A/ja
Publication of DE2551214A1 publication Critical patent/DE2551214A1/de
Application granted granted Critical
Publication of DE2551214C2 publication Critical patent/DE2551214C2/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/42Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/52Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE19752551214 1975-11-12 1975-11-12 Verfahren zur Herstellung von 1,3-oxygenierten 8α-Östratrienen Expired DE2551214C2 (de)

Priority Applications (10)

Application Number Priority Date Filing Date Title
DE19752551214 DE2551214C2 (de) 1975-11-12 1975-11-12 Verfahren zur Herstellung von 1,3-oxygenierten 8α-Östratrienen
DK476376A DK137682C (da) 1975-11-12 1976-10-21 Fremgangsmaade til fremstilling af 1,3-oxygenerede 8alfa-oestratriener
GB4638576A GB1571181A (en) 1975-11-12 1976-11-08 Process for the manufacture of 1,3-oxygenated , -oestratrienes
CH1404576A CH623061A5 (en) 1975-11-12 1976-11-08 Process for the preparation of 1,3-oxygenated 8 alpha oestratrienes
LU76163A LU76163A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-11-12 1976-11-10
FR7634119A FR2331568A1 (fr) 1975-11-12 1976-11-12 Procede de preaparation de derives du 8a-oestratriene
BE172327A BE848301A (fr) 1975-11-12 1976-11-12 Procede de preparation de 8 alpha-oestratrienes 1,3-oxygene, et produit obtenus
US05/741,497 US4066674A (en) 1975-11-12 1976-11-12 Process for the preparation of 1,3-oxygenated 8α-estratrienes and novel intermediates obtained therefrom
NL7612609A NL7612609A (nl) 1975-11-12 1976-11-12 Werkwijze voor het bereiden van 1,3-geoxyge- neerde 8(alpha)-ostratienen.
JP13619776A JPS5262264A (en) 1975-11-12 1976-11-12 Production of 1*33oxygenn added 8 alphaaestratrinne

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752551214 DE2551214C2 (de) 1975-11-12 1975-11-12 Verfahren zur Herstellung von 1,3-oxygenierten 8α-Östratrienen

Publications (2)

Publication Number Publication Date
DE2551214A1 DE2551214A1 (de) 1977-06-02
DE2551214C2 true DE2551214C2 (de) 1984-07-12

Family

ID=5961776

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752551214 Expired DE2551214C2 (de) 1975-11-12 1975-11-12 Verfahren zur Herstellung von 1,3-oxygenierten 8α-Östratrienen

Country Status (8)

Country Link
JP (1) JPS5262264A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE848301A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH623061A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2551214C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK137682C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2331568A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1571181A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU76163A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1374699A (fr) * 1963-11-08 1964-10-09 Aspro Nicholas Ltd Synthèse des 3-éthers de la delta 8, 14-bis dehydro-oestrone
DK133051C (da) * 1973-07-13 1976-08-16 Schering Ag Analogifremgangsmade til fremstilling af 1,3-oxygenerede 8alfa-ostratriener
DE2336431C2 (de) * 1973-07-13 1982-09-23 Schering Ag, 1000 Berlin Und 4619 Bergkamen 1.3-oxygenierte 8 alpha-Östratriene, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Also Published As

Publication number Publication date
LU76163A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-05-18
DK476376A (da) 1977-05-13
FR2331568A1 (fr) 1977-06-10
CH623061A5 (en) 1981-05-15
JPS5262264A (en) 1977-05-23
DK137682B (da) 1978-04-17
DK137682C (da) 1978-10-23
DE2551214A1 (de) 1977-06-02
BE848301A (fr) 1977-05-12
GB1571181A (en) 1980-07-09

Similar Documents

Publication Publication Date Title
DE1618980A1 (de) Durch ungesaettigte Kohlenwasserstoffreste in 17-Stellung substituierte 11,13ss-Dialkylgon-4-en-3,17ss-diole und deren Ester
DE2511410C2 (de) 12-Oxo-15-hydroxy-tetradecancarbonsäurelactone und Verfahren zu ihrer Herstellung
DE2551214C2 (de) Verfahren zur Herstellung von 1,3-oxygenierten 8α-Östratrienen
DE2257533A1 (de) Gesamtsynthese von prostaglandin e tief 1
DE2347172A1 (de) Prostaglandin e tief 1-synthese
DE2130654A1 (de) (+)-Prostaglandin E? und Verfahren zu seiner Herstellung
DE2336438C2 (de) Verfahren zur Herstellung von 17 β- Oxalylsteroiden
DE2918747A1 (de) Tricyclo- alpha , beta -ungesaettigte-ketone
DE69218729T2 (de) Verfahren zur Herstellung von (+)-Estronderivaten
DE842051C (de) Verfahren zur Herstellung von Hydrofluoren-2-carbonsaeuren und ihren Derivaten
DE2253089A1 (de) Verfahren zur herstellung von 9,10seco-oestran-derivaten
EP0136662B1 (de) 2,6-Dioxa-Bicyclo-[2,2,2]-octan-7-yl-acetaldehyde
WO1988003527A1 (en) Improved keto-reduction of carbacycline intermediates
DE2626288A1 (de) Verfahren zur stereoselektiven reduktion von prostaglandinzwischenprodukten
AT232203B (de) Verfahren zur Herstellung von 3β-Hydroxy-6-methyl-Δ<5>-steroiden
DE2260447C3 (de) Verfahren zur Herstellung von Methyljasmonat
DE2415676A1 (de) Hydroxylierte derivate von 5alphacholestan-verbindungen und verfahren zu deren herstellung
DE1264441B (de) Verfahren zur Herstellung von 17alpha-AEthinyl-delta 5(10-19-nor-androsten-17beta-ol-3-on und 17alpha-AEthynil-19-nor-testosteron sowie dessen Estern
AT340606B (de) Verfahren zur herstellung von (androst-17beta-yl)-alfa-pyronen
DE1518246C (de) Verfahren zur Herstellung von Saccharose estern von substituierten Stearinsäuren
DE2613701C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP0270481A1 (de) Neues Verfahren zur Herstellung von optisch aktiven Carbacyclin-Zwischenprodukten
DE1643055B2 (de) Verfahren zur herstellung von cardenoliden
DE2014757A1 (de) Verfahren zur Herstellung optisch aktiver Bicycloalkan Derivate
CH390910A (de) Verfahren zur Herstellung von 19-Nor- 5-androsten-3B,17B-diolen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8320 Willingness to grant licences declared (paragraph 23)
8330 Complete disclaimer